News Boundless Bio raises $100m for circular DNA cancer therapy Boundless Bio’s plans to develop a new class of cancer therapies targeting DNA found outside the nucleus of malignant cells have been boosted by a $100 million fundraising
R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations.
Events Partner Content Oligonucleotide Therapeutics and Delivery Conference Oligonucleotide Therapeutics and Delivery
Digital Developing with start-up DNA As head of digital at Sandoz, Andre Heeg is at the forefront of transformation both within his company and the wider industry.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.